Stephen T Worland's Net Worth
-$380 Thousand
Who is Stephen T Worland?
Stephen T Worland does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GenMark Diagnostics, Inc., eFFECTOR Therapeutics, Inc., Tracon Pharmaceuticals, Inc., and ANADYS PHARMACEUTICALS INC.
SEC CIK
Stephen T Worland's CIK is 0001283307
Past Insider Trading and Trends
2021 was Stephen T Worland's most active year for acquiring shares with 8 total transactions. Stephen T Worland's most active month to acquire stocks was the month of April. 2008 was Stephen T Worland's most active year for disposing of shares, totalling 3 transactions. Stephen T Worland's most active month to dispose stocks was the month of April. 2005 saw Stephen T Worland paying a total of $74,930.00 for 160,800 shares, this is the most they've acquired in one year. In 2023 Stephen T Worland cashed out on 33,799 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GenMark Diagnostics, Inc. No price found
InvestorStephen T Worland owns 20,599 units of Common Stock. From 2012 to 2014 Stephen T Worland acquired a total of 20,599 shares in GenMark Diagnostics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.04% | 5.68K |
—
|
—
| 20.6K |
May 29
| |||
Form 4
|
∞
| 14.92K |
—
|
—
| 14.92K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $0.0783
Chief Executive OfficerStephen T Worland owns 12,494 units of Common Stock which is worth $978.28. From 2021 to 2024 Stephen T Worland acquired a total of 269,010 shares in eFFECTOR Therapeutics, Inc. at a cost of $59,569.42.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.90% | 1.81K |
$1.68 | $3,039.50 | 12.49K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +2.29% | 5.98K |
$0.50 | $2,973.36 | 267.2K |
Nov 15
| |||
Form 4
| +14.86% | 33.8K |
$0.52 | $17,575.48 | 261.23K |
Aug 11
| |||
Form 4
| +2.90% | 6.4K |
$0.46 | $2,938.06 | 227.43K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| +2.81% | 6.05K |
$0.47 | $2,832.41 | 221.03K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +10.26% | 20K |
$1.37 | $27,400.00 | 214.98K |
Jun 7
| |||
Form 4
| +0.95% | 1.84K |
$1.53 | $2,810.61 | 194.98K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
| +134.35% | 755.48K |
$10.00 |
—
| 1.32M |
Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.13925
InvestorStephen T Worland owns 7,500 units of Common Stock which is worth $1,044.38. In the year 2015 Stephen T Worland filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANADYS PHARMACEUTICALS INC No price found
President and CEOStephen T Worland owns 72,317 units of Common Stock. From 2006 to 2010 Stephen T Worland acquired a total of 109,298 shares in ANADYS PHARMACEUTICALS INC at a cost of $322,429.10.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| +88.23% | 33.9K |
$2.95 | $99,999.10 | 72.32K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
| +255.52% | 150K |
$2.04 | $305,937.84 | 208.7K |
Aug 30 - Sep 4
| |||
Form 4/A
| +702.84% | 25K |
$2.95 | $73,750.00 | 28.56K |
Jan 12
| |||
Form 4
| +966.74% | 25K |
$2.95 | $73,750.00 | 27.59K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
| -6.38% | -4.00K |
$16.00 | -$64,000.00 | 58.7K |
Scheduled
|
Mar 16
| ||
Form 4/A
| -4.57% | -3.00K |
$14.00 | -$42,000.00 | 62.7K |
Scheduled
|
Mar 2
| ||
Form 4
| -4.54% | -3.00K |
$14.00 | -$42,000.00 | 63.08K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
| +2,668.07% | 25.4K |
$2.95 | $74,930.00 | 26.35K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||